Published in BMJ on August 23, 2011
Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med (2012) 5.64
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol (2009) 4.17
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Med (2008) 2.20
A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. J Clin Psychiatry (2004) 1.74
Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database Syst Rev (2015) 1.58
Lack of evidence for the efficacy of memantine in mild Alzheimer disease. Arch Neurol (2011) 1.42
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database Syst Rev (2012) 1.30
Alpha-synuclein pathology in the olfactory pathways of dementia patients. J Anat (2007) 1.08
Effectiveness of acetylcholinesterase inhibitors: diagnosis and severity as predictors of response in routine practice. Int J Geriatr Psychiatry (2006) 1.01
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev (2014) 0.96
Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia. Alzheimers Dement (2012) 0.95
Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review. BMJ Open (2012) 0.95
Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease. Neurosci Lett (2002) 0.93
(11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev (2014) 0.92
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting. Cochrane Database Syst Rev (2015) 0.91
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults. Cochrane Database Syst Rev (2015) 0.89
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. Trials (2009) 0.86
Does telecare prolong community living in dementia? A study protocol for a pragmatic, randomised controlled trial. Trials (2013) 0.86
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations. Cochrane Database Syst Rev (2014) 0.84
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) setting. Cochrane Database Syst Rev (2014) 0.82
Metal protein attenuating compounds for the treatment of Alzheimer's dementia. Cochrane Database Syst Rev (2014) 0.79
Metal protein attenuating compounds for the treatment of Alzheimer's dementia. Cochrane Database Syst Rev (2012) 0.77
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings. Cochrane Database Syst Rev (2016) 0.76
Willingness-to-pay for reductions in care need: estimating the value of informal care in Alzheimer's disease. Int J Geriatr Psychiatry (2010) 0.76
Pharmacological interventions for cognitive decline in people with Down syndrome. Cochrane Database Syst Rev (2015) 0.76
Effect of an educational video on the accuracy of surrogate decisions: the case of electroconvulsive therapy. J ECT (2010) 0.75
Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies. Int J Geriatr Psychiatry (2009) 0.75